Double-phase parathyroid scintigraphy in dogs using technetium-99m-sestamibi

Veterinary Radiology and Ultrasound

Volumn 41, Issue 5, 2000, Pages 461-469

  Matwichuk, Cary L ^a,b,c   Taylor, Susan M ^a   Daniel, Gregory B ^b   Wilkinson, A A ^a   Matte, Gilbert G ^a   Dudzic, E M ^a   Shmon, Cindy L ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b UNIVERSITY OF TENNESSEE   (United States)

^c Dept of Small Anim Clin Sciences ^*  (United States)

Author keywords

99mTc sestamibi; Parathyroid scintigraphy

Indexed keywords

CANIS FAMILIARIS;

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; LABORATORY DIAGNOSIS; METHODOLOGY; PARATHYROID DISEASE; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ANIMALS; DOG DISEASES; DOGS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; PARATHYROID DISEASES; RADIONUCLIDE IMAGING; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0034279977     PISSN: 10588183     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2000.tb01872.x     Document Type: Article

References (28)

1. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and Localization of Parathyroid Adenomas in Patients with Hyperparathyroidism Using a Single Radionuclide Imaging Procedure with Technetium-99m-Sestamibi (Double-Phase Study). J Nucl Med 1992;33:1801-1807.
2. Blanco I, Carril JM, Banzo I, et al. Double-Phase Tc-99m Sestamibi Scintigraphy in the Preoperative Location of Lesions Causing Hyperparathyroidism. Clin Nucl Med 1998;23:291-297.
3. Caixas A, Berna L, Piera J, et al. Utility of 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clinical Endocrinology 1995;43:525-530.
4. Klieger P, O'Mara R. The Diagnostic Utility of Dual Phase Tc-99m Sestamibi Parathyroid Imaging. Clin Nucl Med 1998;23:208-211.
5. Lee VS, Wilkinson RH, Leight GS, Coogan AC, Coleman RE. Hyperparathyroidism in High-Risk Surgical Patients: Evaluation with Double-Phase Technetium-99m-Sestamibi Imaging. Radiology 1995;197: 627-633.
6. McHenry CR, Lee K, Saadey J, Neumann DR, Esselstyn CB. Parathyroid Localization with Technetium-99m-Sestamibi: A Prospective Evaluation. J Am Coll Surg 1996;183:25-30.
7. Piga M, Bolasco P, Satta L, et al. Double-Phase Parathyroid Technetium-99m-MIBI Scintigraphy to Identify Functional Autonomy in Secondary Hyperparathyroidism. J Nucl Med 1996;37:565-569.
8. Wei JP, Burke GJ. Analysis of Savings in Operative Time for Primary Hyperparathyroidism Using Localization With Technetium 99m Sestamibi Scan. Am J Surg 1995;170:488-491.
9. Matwichuk CL, Taylor SM, Wilkinson AA, et al. Use of technetium Tc 99m sestamibi for detection of a parathyroid adenoma in a dog with primary hyperparathyroidism. JAVMA 1996;209:1733-1736.
10. Mitchell BK, Kinder BK, Cornelius E, Stewart AF. Journal of Clinical Endocrinology and Metabolism 1995;80:7-9.
11. Carpentier A, Jeannotte S, Verreault J, et al. Preoperative Localization of Parathyroid Lesions in Hyperparathyroidism: Relationship Between Technetium-99m-MIBI Uptake and Oxyphil Cell Content. J Nucl Med 1998;39:1441-1444.
12. Chen EM, Mishkin FS. Parathyroid Hyperplasia May Be Missed by Double-phase Tc-99m Sestamibi Scintigraphy Alone. Clin Nucl Med 1997; 22:222-226.
13. Khan A, Samtani S, Varma V, Frost A, Cohen J. Preoperative parathyroid localization: Prospective evaluation of technetium 99m sestamibi. Otolaryngol Head Neck Surg 1994;111:467-472.
14. Bernard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid Washout of Technetium-99m-MIBI from a Large Parathyroid Adenoma. J Nucl Med 1995;36:241-243.
15. Steyn PF, Ogilvie G. The Non-Cardiac Distribution of 99mTc-Methoxy-Isobutyl-Isonitrile (Sestamibi) in Normal Beagles. Vet Radiol Ultrasound 1995;36:160-163.
16. Gallowitsch HJ, Mikosch P, Kresnik E, Gomez I, Lind P. Technetium 99m Tetrofosmin Parathyroid Imaging-Results with Double-Phase Study and SPECT in Primary and Secondary Hyperparathyroidism. Investigative Radiology 1997;32:459-465.
17. Kipper MS, LaBarbera JJ, Krohn LD, Marcou LM. Localization of a Parathyroid Adenoma by the Addition of Pinhole Imaging to Tc-99m Sestamibi Dual-Phase Scintigraphy-Report of a Case and Review of Experience. Clin Nucl Med 1997;22:73-75.
18. Fjeld JG, Erichsen K, Pfeffer PF, Clausen OPF, Rootwelt K. Technetium-99m-Tetrofosmin for Parathyroid Scintigraphy: A Comparison with Sestamibi. J Nucl Med 1997;38:831-834.
19. Sutter CW, Joshi MJ, Stadainik RC. Noncardiac Uptake of Technetium-99m-MIBI. Semin Nucl Med 1994;24:84-86.
20. Shih WJ, Rastogi A, Stipp V, Gross KK, Coupai JJ, Magoun S. Tc-99m MIBI thoracic SPECT for the detection of intrathoracic tumor masses. Clin Nucl Med 1998;23:594-600.
21. Shih WJ, Rastogi A, Stipp V, Magoun S, Coupal J. Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging. Clin Nucl Med 1998;23:505-508.
22. 99mTc-Sestamibi Scintimammography and Trans-Scan in Diagnosing Breast Cancer. J Nucl Med 1999;40:376-380.
23. 99mTc-MIBI Scintimammography Using a Dedicated Nuclear Mammograph. J Nucl Med 1999;40:46-51.
24. Villaneuva-Meyer J, Leonard MH, Briscoe E, et al. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 1996;37:926-930.
25. Bom HS, Kim YC, Song HC, Min JJ, Kim JY, Park KO. Technetium-99m-MIBI uptake in small cell lung cancer. J Nucl Med 1998;39: 91-94.
26. Kostakoglu L, Kiratli P, Ruacan S, et al. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med 1998;39:228-234.
27. Wisner ER, Penninck D, Biller DS, Feldman EC, Drake C, Nyland TG, High-resolution parathyroid sonography. Vet Radiol Ultrasound 1997; 38:462-466.
28. Wisner ER, Nyland TG, Feldman EC, Nelson RW, Griffey SM. Ultrasonographic evaluation of the parathyroid glands in hypercalcemic dogs. Vet Radiol Ultrasound 1993;34:108-111.